28 November 2024
Herbert Smith Freehills advises Vitrafy Life Sciences on its successful A$117.5 million IPO
Advising firms
Deal team
4 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Alex Mackinnon Lead | Herbert Smith Freehills Kramer | Partner | Not stated | Not stated |
| Jessica Voong | Herbert Smith Freehills Kramer | Senior associate | Not stated | Not stated |
| Bevan Wang | Herbert Smith Freehills Kramer | Not stated | Not stated | Not stated |
| Shamana Rofaeel | Herbert Smith Freehills Kramer | Not stated | Not stated | Not stated |
1 more lawyer on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- AUD 118m (A$117.5 million)
- What the figure measures
- Enterprise value
- Client
- Vitrafy Life Sciences LimitedIssuer
- Counterparties
- Not stated